Date post: | 11-May-2015 |
Category: |
Documents |
Upload: | hospira2010 |
View: | 1,159 times |
Download: | 3 times |
Sedation in the ICU:Liberation strategies
for improved outcomes
Leanne Boehm, MSN, RN, ACNS-BCDelirium and Cognitive Impairment Study Group
Vanderbilt University Medical Center
Nashville, TN USA
Disclosures
• Hospira
Need for Sedation & Analgesia
• Prevention of pain and anxiety
• Decrease oxygen consumption
• Decrease the stress response
• Patient-ventilator synchrony
• Avoid adverse neurocognitive sequelae
• Depression, PTSD
Rotondi AJ, et al. Crit Care Med. 2002;30:746-52A.Weinert C, et al. Curr Opin in Crit Care. 2005;11(4):376-380.Kress JP, et al. J Respir Crit Care Med. 1996;153:1012-1018.
Pitfalls of sedatives and analgesics
• Oversedation:• Failure to initiate spontaneous breathing trials (SBT)
leads to increased duration of mechanical ventilation
• Longer duration of ICU stay
• Impede assessment of neurologic function
• Increase risk for delirium
• Numerous agent-specific adverse events
Kollef M, et al. Chest. 1998;114:541-548.Pandharipande, et al. Anesthesiology. 2006;124:21-26.
Identifying and Treating Pain
Behavioral Pain Scale (BPS) 3-12
Payen JF, et al. Crit Care Med. 2001;29(12):2258-2263.
Item Description Score
Facial expression
Relaxed 1
Partially tightened (eg, brow lowering) 2
Fully tightened (eg, eyelid closing) 3
Grimacing 4
Upper limbs
No movement 1
Partially bent 2
Fully bent with finger flexion 3
Permanently retracted 4
Compliance with ventilation
Tolerating movement 1
Coughing but tolerating ventilation for most of the time
2
Fighting ventilator 3
Unable to control ventilation 4
A note on pain control
• Pain can cause agitation and lead to excessive use of sedatives
• Adequate pain management often reduces the need for sedation1
• Reports suggest narcotic-based sedation may result in improved patient outcomes2-3
1 Kress JP et al, AJRCCM 2002; 168(8): 1024-8
2 Breen D et al, Crit Car 2005; 9(3): R200-10
3 Pandharipande P & Ely EW, Crit Car 2005; 9(3): 247-8
Analgosedation• “Analgesia-first sedation” & sedative if needed
• Increasingly used in many countries
• Acknowledges discomfort as a cause of agitation
• Usually continuous infusion
• 30-74% required benzodiazepine/propofol rescue
• Study of remifentanil vs midazolam sedation
– Reduction in vent time (2 d) and ICU LOS (1d)
• Not appropriate for drug or alcohol withdrawal
Dahaba AA, et al. Anesthesiology. 2004;101:640-646.Park G, et al. Br J Anaesth. 2007;98:76-82. Rozendall FW, et al. Intensive Care Med. 2009;35:291-298.Strøm T, et al. Lancet. 2010;375(9713):475-480
Sedation assessment and maintaining a
sedation goal
Sedation Scales
Pun & Dunn, AJN 2007; 107(7):40-48
Richmond Agitation Sedation Scale (RASS)
Ely EW, et al. JAMA. 2003;289(22):2983-2991.Sessler CN, et al. Am J Respir Crit Care Med. 2002;166(10):1338-1344.
Verbal Stimulus
Physical Stimulus
ICU Sedation: The Balancing Act
Oversedation
Patient Comfort and Ventilatory Optimization
GOAL
Undersedation• Patient recall• Device removal• Ineffectual mechanical ventilation• Initiation of neuromuscular blockade• Myocardial or cerebral ischemia• Decreased family satisfaction w/ care• Severe discomfort• Hypertension• Tachycardia• Increased ICP• Increase metabolic demand• Delirium
• Prolonged mechanical ventilation• Increase length of stay• Increased risk of complications (I.e. VAP)• Increased diagnostic testing• Inability to evaluate for delirium• Cardio/respiratory depression• Decreased GI motility• Immunosuppression• Delirium
Jacobi J, et al. CCM. 2002;30:119-141Carrasco G. Crit Care. 2000;4:217-225
McGaffigan PA. CCN. 2002;Feb(suppl):29-36Blanchard AR. Postgrad Med. 2002;111:59-74
ASHP Therapeutic Guidelines. Best Practices for Health-System Pharmacy. 2003-2004;486-512
Setting Targets
1Bekker AY, et al. Neurosurgery 2005;57(1 Suppl 1):1-10
Aim for Cooperative:• Calm & Easily Arousable State while minimizing pain,
anxiety, or agitation unless contraindicated
• Easy transition from sleep to wakefulness1
• Can participate in weaning and physical therapy1
• Perform therapeutic maneuvers
• Able to perform a cognitive evaluation
Adjust depending on patient need• Over the course of Illness/Treatment
• Initial Intubation vs Stabilization
• Weaning Phase
The importance of preventing and
identifying delirium
What is delirium?
• Common clinical syndrome that is characterized by:
– Inattention
– Acute cognitive dysfunction
• Thought to be due to disruption of neurotransmission related to:
– Drug toxicity
– Inflammation
– Acute stress responses
Delirium
Morandi, A et al., ICM 2009;34:1907-15
Prevalence of Delirium in the ICU
• 60–80% MICU/SICU/TICU ventilated patients develop delirium
• 20–50% of lower severity ICU patients develop delirium
• Majority goes undiagnosed if routine monitoring is not implemented
• Hypoactive or mixed forms most common
Ouimet S, et al. Intensive Care Med. 2007;33:66-73 Ely EW, et al. JAMA. 2001;286,2703-2710Pandharipande PP, et al. J Trauma. 2008;65:34-41Ely EW, et al. Intensive Care Med. 2001;27:1892-1900.Dubois MJ, et al. Intensive Care Med 2001;27:1297-1304
Patient FactorsIncreased ageAlcohol useMale genderLiving aloneSmokingRenal diseaseDepressionVision/Hearing impaired
EnvironmentAdmission via ED or through transferIsolationNo clockNo daylightNo visitorsNoiseUse of physical restraintsSleep deprivation
Predisposing DiseaseCardiac diseaseCognitive impairment (eg, dementia)Pulmonary diseaseHIV
Acute IllnessLength of stayFeverMedicine service Lack of nutritionHypotensionSepsisMetabolic disorders Tubes/cathetersMedications:- Anticholinergics- Corticosteroids- Benzodiazepines
Less Modifiable
More Modifiable
DELIRIUM
Inouye SK, et al. JAMA .1996;275:852. Van Rompaey B, et al. Crit Care 2009;13:R77.Skrobik Y. Crit Care Clin. 2009;25(3):585-591. Devlin J, et al. ICM, 2007; 33:929-940.
After Hospital Discharge
During the ICU/Hospital Stay
Sequelae of Delirium
- Increased mortality - 3x greater re-intubation rate - Average 10 additional days in hospital - Higher costs of care
- Increased mortality - Long-term cognitive impairment- D/c requirement for chronic care facility- Decreased functional status at 6 months
Milbrandt EB, et al. Crit Care Med. 2004;32:955-962. Nelson JE, et al. Arch Intern Med. 2006;166:1993-1999.Ely EW, et al. JAMA. 2004;291:1753-1762. Jackson JC, et al. Neuropsychol Rev. 2004;14(2):87-98.
Intensive Care Delirium Screening Checklist
1. Altered level of consciousness
2. Inattention
3. Disorientation
4. Hallucinations
5. Psychomotor agitation or retardation
6. Inappropriate speech
7. Sleep/wake cycle disturbances
8. Symptom fluctuation
Bergeron N, et al. Intensive Care Med. 2001;27:859-864.Ouimet S, et al. Intensive Care Med. 2007;33:1007-1013.
Score 1 point for each component present during shift • Score of 1-3 = Subsyndromal Delirium• Score of ≥ 4 = Delirium
Confusion Assessment Method(CAM-ICU)
or3. Altered level of
consciousness4. Disorganized
thinking
= Delirium
Ely EW, et al. Crit Care Med. 2001;29:1370-1379.Ely EW, et al. JAMA. 2001;286:2703-2710.
1. Acute onset of mental status changes or a fluctuating course
2. Inattention
and
and
Feature 1: Alteration/Fluctuation in Mental Status
Is the pt different than his/her baseline mental status? OR
Has the patient had any fluctuation in mental status in the past 24 hours (eg fluctuating
RASS, GCS, previous delirium assessments, etc)?
Positive/Present: If either question is YES.
Feature 2: Inattention
Attention Screening Exam
• Auditory: Letter “A”– Say 10 letters & tell patient to squeeze on “A”– Letters: S A V E A H A A R T– Scoring: Count error if patient fails to squeeze on “A” and
when they squeeze on any letter other than “A”
• Visual: Pictures– Similar to letters but with pictures
Positive/Present: If score is <8
Feature 4: Alt Level of Consciousness
Any LOC other than Alert.
Positive/Present: If the Actual RASS score is anything other than “0”
Feature 3: Disorganized Thinking
A: Yes/No Questions1. Will a stone float on water? 2. Are there fish in the sea? 3. Does one pound weigh more than two pounds?4. Can you use a hammer to pound a nail?
B: CommandSay to patient: “Hold up this many fingers” (Examiner holds two fingers in front of patient) “Now do the same thing with the other hand” (Not repeating the number of fingers).
Positive/Present: If combined score (questions + command) is less than 4
If sedation is required,what is the optimal
sedative choice?
Characteristics of an Ideal Sedative
• Rapid onset of action allows rapid recovery after d/c1
• Effective at providing adequate sedation with predictable dose response1,2
• Easy to administer1,3
• Lack of drug accumulation1
• Few adverse effects1-3
• Minimal adverse interactions with other drugs1-3
• Cost-effective3
• Promotes natural sleep4
1. Ostermann ME, et al. JAMA. 2000;283:1451-1459.2. Jacobi J, et al. Crit Care Med. 2002;30(1):119-141.
3. Dasta JF, et al. Pharmacother. 2006;26:798-805.4. Nelson LE, et al. Anesthesiol. 2003;98:428-436.
Choice of Sedatives Benzodiazepines
– GABAA receptor modulation in CNS• Facilitates binding of GABA
– Hyperpolarize cells, making them more resistant to excitation Propofol
– Not well understood – GABA receptor modulation is likely
Dexmedetomidine– α2-adrenergic agonist (inhibits NE release in CNS & PNS)
• CNS: sedation/hypnosis, anxiolysis, and analgesia• PNS: decreases BP and HR; activates endogenous sleep-promoting
pathway– No respiratory suppression– Enables cognitive evaluation & patient communication
Consider Comorbidities When Choosing a Sedation
Regimen• Chronic pain
• Organ dysfunction
• CV instability
• Substance withdrawal
• Respiratory insufficiency
• Obesity
• Obstructive sleep apnea
Risk of delirium with benzodiazepines
Pandharipande P, et al. J Trauma. 2008; 65:34-41. Pandharipande P, et al. Anesthesiol. 2006:104:21-26.
Propofol vs benzodiazepines
Outcomes improved by propofol: sedation quality, ventilator synchrony, time to awakening, variability of awakening, time to extubation from discontinuation of sedation, overall time to extubation, ventilator days, ICU LOS among survivors, costs of sedation
MENDS
MICU/SICU PatientsVentilated & Sedated
N=103
ControlLorazepam (GABA)
± Fentanyl
InterventionDexmedetomidine (α2)
± Fentanyl
Pandharipande PP, et al. JAMA 2007;298:2644-53
• Double-blind RCT of dexmedetomidine vs lorazepam infusion• Intervention:
– Dexmedetomidine 0.15–1.5 mcg/kg/hr– Lorazepam infusion 1–10mg/hr
• No daily interruption, patient targeted sedation
MENDS: dexmedetomidine vs
lorazepam
Pandharipande P et al – JAMA, 2007; 298:2644-2653
Dexmedetomidine resulted in:
• More days alive without delirium or coma (p=.01)
• Lower prevalence of coma (p=.001)
• More time spent within sedation goals (p=.04)
Differences in 28-day mortality and delirium-free days were not significant
SEDCOM
MICU PatientsVentilated & Sedated
n=366
ControlMidazolam (GABA)
± Fentanyl
InterventionDexmedetomidine (α2)
± Fentanyl
Riker, R., et al. JAMA 2009; 301(5): 489-499
• Double-blind, RCT comparing long-term dexmedetomidine vs midazolam
• Sedatives (dex 0.2-1.4 μg/kg/hr or midaz 0.02-0.1 mg/kg/hr) titrated for light sedation, administered up to 30 days
• Daily arousal assessments and drug titration Q4h
SEDCOM:dexmedetomidine vs
midazolam Dexmedetomidine resulted in:
• less time on the ventilator (p=.01)
• less delirium (p<.001)
• less tachycardia (p<.001)
• less hypertension (p=.02)
Most notable adverse effect of dexmedetomidine was bradycardia (p<.001)
Strategies to Reduce the Duration of Mechanical Ventilation in Patients Receiving Continuous
Sedation
Daily sedation interruption decreases days of MV
• Hold infusion until patient awake, then restart at 50% of prior dose
• “Awake” defined as 3 of the following 4:– Open eyes in response to voice– Use eyes to follow investigator
on request– Squeeze hand on request– Stick out tongue on request
Kress JP, et al. N Engl J Med. 2000;342:1471-1477.
• Fewer diagnostic tests to assess changes in mental status• No increase in rate of agitated-related complications or episodes of patient-initiated device removal• No increase in PTSD or cardiac ischemia
The ABC Trial(both groups get patient targeted sedation)
OUTCOMESdelirium, LOS, 12-mo NPS testing, QOL
Spontaneous Breathing Trial (SBT)ventilator off
safely monitored
OUTCOMESdelirium, LOS, 12-mo NPS testing, QOL
Spontaneous Breathing Trial (SBT)ventilator off
safely monitored
Spontaneous Awakening Trial (SAT)turn sedation/narcotics off
monitor safely
Medical ICU on VentilatorSurrogate Informed Consent
Control Intervention
Girard TD, et al. Lancet. 2008;371:126-134.
The ABC TrialSBT+usual care vs SAT+SBT
• Patients in the intervention group:– Less time in coma (p=.002)– 2 days less on the ventilator (p=.02)– 4 days less in the ICU (p=.02)– 4 days less in the hospital (p=.04)– Less exposure to benzodiazepines– Were more likely to be alive in 1 year (p=.01)– More self extubations, but not more
reintubations
Girard TD, et al. Lancet. 2008;371:126-134.
Early Mobilization
Schweickert et al, Lancet 2009;373:1874-82
Mobility
• A fundamental nursing activity
• Enhances gas exchange
• Reduces VAP rates
• Shortened duration of MV
• Enhances long-term functional ability
Schweickert WD, et al. Lancet. 2009;373:1874-1882.
24% improvement (1.7-fold better) return to independent functional status at discharge
(NNT=4)
Daily Wake-Up + Early Mobility
OutcomeIntervention
(n=49)Control(n=50) P
Functionally independent at discharge 29 (59%) 19 (35%) .02
ICU delirium (days) 2.0 (0.0-6.0) 4.0 (2.0-7.0) .03
Time in ICU with delirium (%) 33% (0-58) 57% (33-69) .02
Hospital delirium (days) 2.0 (0.0-6.0) 4.0 (2.0-8.0) .02
Hospital days with delirium (%) 28% (26) 41% (27) .01
Barthel Index score at discharge 75 (7.5-95) 55 (0-85) .05
ICU-acquired paresis at discharge 15 (31%) 27 (49%) .09
Ventilator-free days 23.5 (7.4-25.6) 21.1 (0.0-23.8) .05
Length of stay in ICU (days) 5.9 (4.5-13.2) 7.9 (6.1-12.9) .08
Length of stay in hospital (days) 13.5 (8.0-23.1) 12.9 (8.9-19.8) .93
Hospital mortality 9 (18%) 14 (25%) .53
Schweickert WD, et al. Lancet. 2009;373:1874-1882.
Implementation challenges
Many issues to address
Multiple disciplines are involved
– RN, RT, MD, PT/OT, pharmacist
Timing
Coordination, collaboration, & teamwork
Protocol development
Change in culture of workplace
Costs
Resistance to change
Putting it all together
Clinical caseMale patient, age 74
Hx: Dementia, coronary artery disease, diabetes, hypertension
CC: altered mental status, shortness of breath
Currently hypoxic and required MV
Dx: Septic shock, ARDS, acute renal failure
Clinical case
• Current vent settings: A/C 16, TV 400, PEEP 14, FiO2 80%
• Current infusions: norepinephrine 10 mcg/min, vasopressin 0.4 units/min, insulin gtt, IVF
• Assessment: Target RASS -4, actual RASS +1 to -1, displaying vent asynchrony, CAM-ICU positive, bilat rhonchi, pulses present
• Receiving intermittent boluses of fentanyl and lorazepam
Nursing interventions?
Clinical case
Current vent settings: A/C 16, TV 400, PEEP 5, FiO2 40%
Current infusions: propofol 40 mcg/kg/hr, norepinephrine 4 mcg/min, vasopressin 0.4 units/min, insulin gtt, IVF
Intermittent fentanyl for analgesia
Assessment: Target RASS -1, actual RASS -3, CAM-ICU positive, not breathing over vent set rate, bilat rhonchi, pulses present, moving extremities spontaneously
Nursing interventions:for sedation?for delirium? (pharm/nonpharm)
Clinical case
Current vent settings: PS 5, PEEP 5, FiO2 40%, RR 22
Current infusions: Norepinephrine/vasopressin off, insulin gtt, IVF, propofol off
Septic shock resolved, passed SAT/SBT
Assessment: Target RASS 0, actual RASS 0, CAM-ICU positive, lungs clear, moves all extremities
Nursing interventions:for sedation?for delirium? (pharm/nonpharm)
Clinical Case
• What if the patient had not passed the SBT and was beginning to become agitated?
• Would you consider pharmacologic treatment for delirium at this point?
• What if we extubated this patient and he later became agitated?
Summary
Goals for sedation: Are we on the same page?
Daily Sedation Cessation: Did you wake up your patient today?
Sedative Choice: What is the best option for my patient right now?
Roadmap: How do we put it all together at the bedside?